Omp Pylori

Helicobacter Pylori Outer Membrane Protein Recombinant
Shipped with Ice Packs
In Stock

Description

Omp Pylori recombinant antigen is produced in E. coli expressing the H. pylori outer membrane protein having the Mw of 23 kDa. Omp Pylori recombinant antigen is well recognized by specific IgG and IgM from H. pylori infected patients.

Product Specs

Introduction
Helicobacter pylori is a Gram-negative, microaerophilic bacterium found in the stomach, particularly the antrum. It causes chronic inflammation of the stomach lining and is strongly linked to duodenal and gastric ulcers and stomach cancer. Affecting over half of the global population, H. pylori infection is more common in developing nations. Currently, there is no perfect target antigen for diagnosing H. pylori. However, a 23 kDa outer membrane protein has shown promise with good sensitivity and coverage in diagnosing H. pylori infection.
Description
Recombinant Omp Pylori antigen is produced in E. coli, expressing the H. pylori 23 kDa outer membrane protein. This recombinant antigen is effectively recognized by IgG and IgM antibodies from H. pylori infected patients.
Physical Appearance
Sterile, filtered liquid.
Formulation
The recombinant Omp Pylori protein is prepared in 1xPBS with a pH of 7.4.
Stability
While Omp Pylori remains stable at 4°C for up to one week, it is recommended to store it below -18°C. Avoid repeated freeze-thaw cycles.
Purity
Purity exceeds 95% as determined by 12% SDS-PAGE analysis with Coomassie blue staining.
Source
E.Coli
Amino Acid Sequence
MLVTKLAPDFKAPAVLGNNEVDEHFELSKNLGKNGAILFFWP
KDFTFVCPTEIIAFDKRVKDFQEKGFNVIGVSIDSEQVHFAWK
NTPVEKGGIGQVTFPMVADITKSISRDYDVLFEEAIALRGAFLI
DKNMKVRHAVINDLPLGRNADEMLRMVDALLHFEEHGEVCP
AGWRKGDKGMKATHQGVAEYLKENSIKL.
Purification Method
Purified by proprietary chromatographic technique.

Q&A

What are the major outer membrane proteins identified in H. pylori and what functions do they serve?

H. pylori possesses an extraordinarily large set of outer membrane proteins, with the Hop (Helicobacter outer membrane porins) and Hor (Hop-related proteins) groups constituting a large paralogous family of 33 members . Several key OMPs have been identified as adhesins or adherence-associated proteins, including:

  • AlpA and AlpB: Essential adhesins produced by virtually all clinical isolates

  • BabA: Binds to Lewis b blood group antigens

  • SabA: Mediates binding to sialylated antigens

  • HopZ: Adherence-associated protein

  • OipA: Enhances IL-8 production in gastric epithelial cells

These proteins facilitate bacterial attachment to gastric epithelial cells, which theoretical modeling has identified as an important mechanism contributing to chronic colonization of the human stomach .

How prevalent is the expression of different OMPs in clinical H. pylori isolates?

Research examining 200 patient isolates revealed remarkably variable expression patterns among different OMPs:

OMP ProteinExpression RateNotes
AlpA/AlpBNearly 100%Essential function
Other OMPs35% to 73%Highly variable
BabA11% (functional defect)Produced but failed to bind substrate
SabA5% (functional defect)Produced but failed to bind substrate

This variable expression likely reflects adaptation to individual hosts or specific gastric niches .

What is the relationship between H. pylori OMP expression and pathogenicity markers?

Interleukin-8 (IL-8) expression in gastric cells is strictly dependent on the presence of the cag pathogenicity island, whereas the presence of OipA clearly enhances IL-8 production . The presence of the translocated effector protein CagA correlates well with BabA and OipA production, suggesting a coordinated expression of virulence factors . Additionally, certain HopQ OMPs can attenuate H. pylori adherence to gastric epithelial cells, affecting the efficiency of CagA translocation into epithelial cells .

What methodological approaches are recommended for analyzing OMP expression profiles in clinical H. pylori isolates?

When analyzing OMP expression in clinical isolates, researchers should:

  • Generate pure cultures from patient biopsy specimens by isolating single colonies

  • Minimize bacterial passages (2-3 passages maximum) to reduce the risk of phase-variable switching of OMP genes

  • Use immunoblot analysis with specific polyclonal antisera raised against purified fusion proteins of the corresponding OMPs

  • Include well-characterized reference strains (e.g., H. pylori P1, 26695, J99) as controls

  • Culture H. pylori in a microaerobic atmosphere (85% N₂, 10% CO₂, 5% O₂) at 37°C on appropriate media

This methodological approach ensures reliable detection of OMP expression patterns while minimizing artifacts from laboratory cultivation.

How can researchers interpret patterns of OMP co-expression in H. pylori isolates?

Analysis of co-expression patterns requires:

  • Determination of distances between H. pylori strains based on their OMP expression patterns

  • Cluster analysis to identify related expression profiles

  • Heat map visualization to identify OMPs that are frequently co-expressed

Research has identified several distinct co-expression clusters:

  • AlpA and AlpB show the strongest co-production

  • CagA and OipA demonstrate a strong tendency to be co-produced

  • BabA is related to the CagA-OipA pattern

  • HP0227 is more related to AlpA-AlpB

  • BabB, SabA, and HP0317 form another cluster with low relatedness

These patterns may reflect functional relationships between different OMPs or coordinated regulation of their expression.

What experimental approaches can be used to study the functional consequences of OMP expression variability?

To investigate the functional impact of OMP expression variability, researchers should:

  • Correlate OMP profiles with bacterial adherence to different gastric cell lines or tissue samples

  • Measure inflammatory responses (e.g., IL-8 production) in epithelial cells exposed to H. pylori strains with different OMP profiles

  • Generate isogenic mutants lacking specific OMPs to determine their individual contributions

  • Perform complementation studies to confirm phenotypic changes are due to the targeted OMP

  • Examine CagA translocation efficiency in relation to OMP expression patterns

Studies have demonstrated that certain HopQ OMPs can attenuate H. pylori adherence and affect CagA translocation, highlighting the importance of OMP expression profiles in bacterial virulence .

How do allelic variations in OMP genes impact H. pylori virulence and geographic distribution?

The hopQ gene exists as two highly divergent alleles with distinct geographic distributions:

  • Type I hopQ allele: Predominantly found in East Asian H. pylori strains, closely associated with the cagA gene

  • Type II hopQ allele: Commonly found in Western H. pylori strains lacking cagA

These geographic associations suggest co-evolution of virulence factors and potential adaptation to different human populations. Researchers investigating OMP variations should:

  • Sequence OMP genes to identify allelic variants

  • Compare allelic distributions across different geographic regions

  • Correlate allelic variations with clinical outcomes and pathogenicity

  • Examine functional differences between allelic variants through in vitro and in vivo studies

What sample collection and processing protocols are recommended for OMP expression studies?

For optimal results in OMP expression studies:

  • Collect multiple biopsy specimens from different anatomical sites (antrum, corpus, fundus)

  • Process samples rapidly to maintain bacterial viability

  • Isolate single colonies to obtain pure cultures representative of individual strains

  • Store isolates at -80°C for preservation

  • Limit subculturing before analysis to prevent phase variation

In the referenced study, H. pylori bacteria were isolated from antral biopsy specimens from 200 patients, with most isolates (52%) originating from children and young adults (≤20 years) who sought medical attention due to dyspeptic symptoms .

How can researchers address the challenge of OMP phase variation in experimental studies?

H. pylori OMPs can undergo phase variation (reversible switching between ON and OFF states), complicating experimental analysis. To address this:

  • Minimize bacterial passages before analysis (limit to 2-3 passages)

  • Use single colony isolates to establish baseline expression

  • Monitor expression over time to detect potential switching events

  • Sequence OMP gene promoter regions to identify slipped-strand mispairing mechanisms

  • Employ quantitative methods to detect partial expression due to mixed populations

This approach acknowledges the dynamic nature of OMP expression while reducing experimental artifacts.

What statistical approaches are appropriate for analyzing complex OMP expression patterns across clinical isolates?

When analyzing complex OMP expression datasets:

  • Use cluster analysis to identify patterns of co-expression

  • Apply distance metrics to quantify similarities between isolates

  • Generate heat maps for visual representation of expression patterns

  • Use correlation analysis to identify statistically significant associations between OMP expression and clinical or demographic parameters

  • Consider multivariate approaches to account for potential confounding factors

In the referenced study, researchers determined the distances between H. pylori strains based on their OMP expression patterns and performed clustering analysis, with the resulting dendrograms presented as a heat map .

How can researchers reconcile the production of adhesins that fail to bind their substrates?

Studies have observed that in some clinical isolates, adhesins like BabA (11% of isolates) and SabA (5% of isolates) are produced but fail to bind their cognate substrates . This apparent contradiction may be explained by:

  • Post-translational modifications affecting protein function

  • Sequence variations in binding domains

  • Expression of inhibitory factors

  • Methodological limitations in binding assays

Researchers should address this contradiction by:

  • Sequencing adhesin genes to identify mutations affecting binding domains

  • Examining post-translational modifications through proteomics approaches

  • Developing more sensitive binding assays for functional characterization

  • Investigating potential inhibitory factors through co-immunoprecipitation studies

How should researchers interpret the variable relationship between H. pylori infection and extragastric diseases?

To address these contradictions, researchers should:

  • Employ bidirectional Mendelian randomization analyses to investigate potential causal relationships

  • Stratify patients based on H. pylori strains and OMP expression profiles

  • Consider host genetic factors that may influence susceptibility

  • Account for confounding environmental and socioeconomic factors

  • Use longitudinal studies to establish temporal relationships

A recent study using bidirectional two-sample Mendelian randomization analysis found no evidence of a causal relationship between H. pylori infection and IgA nephropathy, nor evidence that IgA nephropathy leads to increased risk of H. pylori infection .

What emerging approaches could enhance our understanding of OMP dynamics in host adaptation?

Future research on H. pylori OMPs should consider:

  • Single-cell analysis to detect heterogeneity within bacterial populations

  • Long-term evolution experiments to track OMP expression changes over time

  • Advanced imaging techniques to visualize OMPs during host-pathogen interactions

  • Systems biology approaches to model OMP regulatory networks

  • Metagenomics analyses to examine H. pylori diversity within individual hosts

The extreme diversity of OMP expression profiles observed in individual H. pylori strains likely reflects selective pressure for adhesion, which may differ across different hosts as well as within an individual over time .

How might OMP expression profiles inform personalized treatment approaches for H. pylori infection?

As H. pylori treatment faces increasing antibiotic resistance challenges, OMP profiling could inform personalized therapy by:

  • Identifying strain-specific adhesion mechanisms that could be targeted

  • Predicting virulence potential based on OMP signatures

  • Selecting appropriate antibiotic combinations based on strain characteristics

  • Developing adhesin-blocking therapies tailored to individual strain profiles

  • Monitoring treatment efficacy through changes in OMP expression

Understanding the complex OMP expression landscape could ultimately lead to more effective, personalized approaches to combat this persistent pathogen that affects approximately half of the world's population .

Product Science Overview

Introduction

Helicobacter pylori is a Gram-negative, microaerophilic bacterium that primarily colonizes the human stomach. It is known for its helical shape and high motility, which is facilitated by its flagella. This bacterium is a significant human pathogen, infecting over half of the world’s population. While many infections are asymptomatic, H. pylori is a recognized risk factor for various gastric disorders, including gastritis, peptic ulcers, and gastric cancer .

Outer Membrane Proteins (OMPs)

The outer membrane of H. pylori is a critical component of its structure and function. It consists of two highly asymmetric layers: the inner monolayer contains phospholipids, while the outer monolayer is composed mainly of outer membrane proteins (OMPs). These OMPs play a crucial role in the bacterium’s ability to adapt to the gastric environment and facilitate infection .

Virulence Factors

H. pylori’s pathogenicity is largely attributed to its virulence factors, including CagA and VacA, as well as its OMPs. These proteins help the bacterium adhere to gastric epithelial cells, colonize the stomach, and evade the host immune response. Some of the well-studied OMPs include BabA (HopS), SabA (HopP), OipA (HopH), HopQ, and HopZ .

Recombinant Outer Membrane Proteins

Recombinant outer membrane proteins of H. pylori are produced using genetic engineering techniques. These proteins are expressed in a host organism, such as Escherichia coli, and then purified for use in research and potential therapeutic applications. The recombinant proteins are used to study the structure, function, and immunogenicity of H. pylori OMPs. They are also being investigated as potential targets for novel therapies and vaccines .

Importance in Research and Medicine

Understanding the role of H. pylori OMPs in the bacterium’s pathogenicity is essential for developing new strategies to combat H. pylori-related diseases. Research on recombinant OMPs has provided valuable insights into the mechanisms of H. pylori infection and its interactions with the host. These studies have also highlighted the potential of OMPs as targets for therapeutic interventions and vaccine development .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.